Galderma Group AG

Galderma Group AG is a leading global pure-play dermatology company dedicated exclusively to skin health. Founded in 1981 and headquartered in Zug, Switzerland, the company offers a science-driven portfolio spanning injectable aesthetics, dermatological skincare, and therapeutic dermatology. It manages a diverse range of internationally recognized brands, including Dysport/Azzalure, Alluzience, Restylane, and Sculptra in aesthetics, as well as Cetaphil and Alastin in skincare. Galderma also provides prescription treatments for conditions such as acne, rosacea, psoriasis, and atopic dermatitis through products like Differin, Epiduo, Soolantra, and Aklief. With operations in over 100 countries, partnerships with healthcare professionals, and a commitment to innovation, Galderma plays a significant role in advancing dermatological science and meeting the needs of patients and consumers worldwide.